LNDT yields 2000000.00% · JNJ yields 2.13%● Live data
📍 LNDT pulled ahead of the other in Year 1
Combined, LNDT + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LNDT + JNJ for your $10,000?
LianDi Clean Technology, Inc., through its subsidiaries, distributes petroleum and petrochemical valves, equipment, and related services in the People's Republic of China. The company distributes unheading units for the delayed coking process; and offers systems integration, and related technical and engineering services to petroleum and petrochemical companies and other energy companies. It also develops and markets optimization software for data collection, performance analysis, and process optimization in the polymerization reaction of ethylene production. In addition, the company is involved in development, manufacture, and sale of organic and inorganic chemical products, and high polymer fine chemical products; provision of chemical professional services and oil tank sludge cleaning services; and recycle and sale of discarded or used packing products. LianDi Clean Technology, Inc. was founded in 2004 and is based in Beijing, the People's Republic of China. As of June 29, 2015, LianDi Clean Technology, Inc. operates as a subsidiary of Smart Specialists Limited.
Full LNDT Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.